OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Showing 13 citing articles:
The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Seltorexant for major depressive disorder
K.L. Valentino, Kayla M. Teopiz, Sabrina Wong, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
K.L. Valentino, Kayla M. Teopiz, Sabrina Wong, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior
Luca Botticelli, Emanuela Micioni Di Bonaventura, Fabio Del Bello, et al.
Pharmacological Research (2023) Vol. 195, pp. 106875-106875
Open Access | Times Cited: 5
Luca Botticelli, Emanuela Micioni Di Bonaventura, Fabio Del Bello, et al.
Pharmacological Research (2023) Vol. 195, pp. 106875-106875
Open Access | Times Cited: 5
Selective Orexin 2 Receptor Blockade Alleviates Cognitive Impairments and the Pathological Progression of Alzheimer’s Disease in 3xTg-AD Mice
Xiaohong Hu, Kai-Yue Yu, Xinxin Li, et al.
The Journals of Gerontology Series A (2024) Vol. 79, Iss. 7
Closed Access | Times Cited: 1
Xiaohong Hu, Kai-Yue Yu, Xinxin Li, et al.
The Journals of Gerontology Series A (2024) Vol. 79, Iss. 7
Closed Access | Times Cited: 1
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Restraint stress-induced antinociceptive effects in acute pain: Involvement of orexinergic system in the nucleus accumbens
Danial Farmani, Seyed Mohammadmisagh Moteshakereh, Mohammad Nikoohemmat, et al.
Behavioural Brain Research (2024) Vol. 472, pp. 115133-115133
Closed Access | Times Cited: 1
Danial Farmani, Seyed Mohammadmisagh Moteshakereh, Mohammad Nikoohemmat, et al.
Behavioural Brain Research (2024) Vol. 472, pp. 115133-115133
Closed Access | Times Cited: 1
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure–activity–relationship, and sleep-promoting properties in rats
Christine Brotschi, Martin H. Bolli, John Gatfield, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 344-354
Closed Access | Times Cited: 2
Christine Brotschi, Martin H. Bolli, John Gatfield, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 344-354
Closed Access | Times Cited: 2
Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease
Joan Biel Rebassa, Toni Capó, Jaume Lillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5378-5378
Open Access
Joan Biel Rebassa, Toni Capó, Jaume Lillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5378-5378
Open Access
The Role of Orexin Receptor Antagonists in Inhibiting Drug Addiction: A Review Article
Peyman Esmaili‐Shahzade‐Ali‐Akbari, Amir Ghaderi, Atena Sadeghi, et al.
Addiction and Health (2024) Vol. 16, Iss. 2, pp. 130-139
Open Access
Peyman Esmaili‐Shahzade‐Ali‐Akbari, Amir Ghaderi, Atena Sadeghi, et al.
Addiction and Health (2024) Vol. 16, Iss. 2, pp. 130-139
Open Access
Novel hybrid motifs of 2-(2-pyridinyl)-1H-benzo[d]imidazole-1,2,3-triazole: Synthesis, anticancer assessment, and in silico study
Salhah D. Al‐Qahtani, Ghadah M. Al‐Senani
Journal of Molecular Structure (2024) Vol. 1318, pp. 139376-139376
Closed Access
Salhah D. Al‐Qahtani, Ghadah M. Al‐Senani
Journal of Molecular Structure (2024) Vol. 1318, pp. 139376-139376
Closed Access
Orexin mechanisms in the prelimbic cortex modulate the expression of contextual conditioned fear
Gabriela V. M. Oliveira, Paloma Molina Hernandes, Fábio H. dos Santos, et al.
Psychopharmacology (2024)
Closed Access
Gabriela V. M. Oliveira, Paloma Molina Hernandes, Fábio H. dos Santos, et al.
Psychopharmacology (2024)
Closed Access
Improving Sleep to Address Co-Occurring Substance Use Disorder and Chronic Pain: Exploring the Potential of the Orexin (Hypocretin) System as a Clinical Target
Chung Jung Mun, Matthew J. Reid, Sarah Sarandos, et al.
Current Addiction Reports (2024)
Closed Access
Chung Jung Mun, Matthew J. Reid, Sarah Sarandos, et al.
Current Addiction Reports (2024)
Closed Access
